AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value

$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie cash and equivalents ($M) ($M)

Form 10-Q / 10-K

Quarterly Annual

Latest, FY2025

5,229

Period ended Dec 31, 2025

Change on a year earlier

-5.3%

5,524 in FY2024

History

16 years

Since FY2010

Sources

Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Cash and equivalents ($M) ($M)	Year on year	Source
FY2025	Dec 31, 2025	5,229	-5.3%	Form 10-K (filed 2026-02-20) ↗
FY2024	Dec 31, 2024	5,524	-56.9%	Form 10-K (filed 2025-02-14) ↗
FY2023	Dec 31, 2023	12,814	+39.3%	Form 10-K (filed 2024-02-20) ↗
FY2022	Dec 31, 2022	9,201	-5.6%	Form 10-K (filed 2023-02-17) ↗
FY2021	Dec 31, 2021	9,746	+15.4%	Form 10-K (filed 2022-02-18) ↗
FY2020	Dec 31, 2020	8,449	-78.8%	Form 10-K (filed 2021-02-19) ↗
FY2019	Dec 31, 2019	39,924	+447.7%	Form 10-K (filed 2020-02-21) ↗
FY2018	Dec 31, 2018	7,289	-21.6%	Form 10-K (filed 2019-02-27) ↗
FY2017	Dec 31, 2017	9,303	+82.4%	Form 10-K (filed 2018-02-16) ↗
FY2016	Dec 31, 2016	5,100	-39.3%	Form 10-K (filed 2017-02-17) ↗
FY2015	Dec 31, 2015	8,399	+0.6%	Form 10-K (filed 2016-02-19) ↗
FY2014	Dec 31, 2014	8,348	-13.0%	Form 10-K (filed 2015-02-20) ↗
FY2013	Dec 31, 2013	9,595	+62.6%	Form 10-K (filed 2014-02-21) ↗
FY2012	Dec 31, 2012	5,901	+21,755.6%	Form 10-Q (filed 2013-05-08) ↗
FY2011	Dec 31, 2011	27	+170.0%	Form 10-Q (filed 2013-05-08) ↗
FY2010	Dec 31, 2010	10	–	Form 10-K (filed 2014-02-21) ↗

Cite this data

StockData. (2026). AbbVie Cash and equivalents ($M) ($M), annual FY2010–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fs_cash

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.